从诊断到预后:重新审视肌肉ISG15过表达在幼年特发性炎症性肌病中的意义
该研究纳入56例患者(24例幼年皮肌炎、12例幼年重叠肌炎、10例Duchenne型肌营养不良、10例先天性肌病),通过肌肉活检免疫组化、免疫印迹和实时定量PCR分析I型干扰素通路调节因子。结果显示肌肉ISG15表达可区分幼年特发性炎症性肌病与非免疫性肌病,并在幼年皮肌炎中区分MDA-5抗体阳性亚组,且ISG15水平与肌肉病理异常严重程度呈负相关、与运动功能呈正相关。
要点
- 肌肉ISG15过表达与幼年皮肌炎强相关,且不同MSA亚型呈现不同ISG15肌肉特征。
- MDA-5阳性的幼年皮肌炎患者ISG15基因和蛋白表达水平最高。
- I型干扰素负调控与较轻的肌肉受累相关。
核心结论
- 肌肉ISG15表达是幼年皮肌炎的有力相关标志,且其表达水平随MSA类别不同而呈现差异。
- MDA-5阳性的幼年皮肌炎患者ISG15基因和蛋白表达均高于其他亚组。
- I型干扰素负调控与较轻的肌肉病理异常和较好的运动功能相关。
研究设计与样本
- 研究纳入56例患者:24例幼年皮肌炎、12例幼年重叠肌炎、10例Duchenne型肌营养不良、10例先天性肌病。
- 肌肉活检样本采用免疫组化、免疫印迹和实时定量聚合酶链反应评估。
- 分析I型干扰素负调控因子(ISG15和USP18)及正调控因子(DDX58和IFIH1)。
主要发现
- ISG15表达可区分幼年特发性炎症性肌病与非免疫性肌病,并在幼年特发性炎症性肌病中区分皮肌炎与重叠肌炎。
- 在幼年皮肌炎患者中,无论MSA状态如何,I型干扰素正调控因子DDX58和IFIH1的上调相似。
- MDA-5阳性患者中I型干扰素负调控因子ISG15水平最高。
- ISG15水平与肌肉组织学异常严重程度呈负相关,与儿童肌炎评估量表和徒手肌力测试评估的运动表现呈正相关。
临床怎么用
- 肌肉ISG15表达可用于辅助鉴别幼年皮肌炎与非免疫性肌病及重叠肌炎。
- MDA-5抗体阳性幼年皮肌炎患者ISG15表达更高,提示I型干扰素负调控与较轻肌肉受累相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Juvenile idiopathic inflammatory/immune myopathies (IIMs) constitute a highly heterogeneous group of disorders with diagnostic difficulties and prognostic uncertainties. Circulating myositis-specific autoantibodies (MSAs) have been recognized as reliable tools for patient substratification. Considering the key role of type I interferon (IFN) up-regulation in juvenile IIM, we undertook the present study to investigate whether IFN-induced 15-kd protein (ISG-15) could be a reliable biomarker for stratification and diagnosis and to better elucidate its role in juvenile IIM pathophysiology. METHODS: The study included 56 patients: 24 with juvenile dermatomyositis (DM), 12 with juvenile overlap myositis (OM), 10 with Duchenne muscular dystrophy, and 10 with congenital myopathies. Muscle biopsy samples were assessed by immunohistochemistry, immunoblotting, and real-time quantitative polymerase chain reaction. Negative regulators of type I IFN (ISG15 and USP18) and positive regulators of type I IFN (DDX58 and IFIH1) were analyzed. RESULTS: ISG15 expression discriminated patients with juvenile IIM from those with nonimmune myopathies and, among patients with juvenile IIM, discriminated those with DM from those with OM. Among patients with juvenile DM, up-regulation of the type I IFN positive regulators DDX58 and IFIH1 was similar regardless of MSA status. In contrast, the highest levels of the type I IFN negative regulator ISG15 were observed in patients who were positive for melanoma differentiation-associated gene 5 (MDA-5). Finally, ISG15 levels were inversely correlated with the severity of muscle histologic abnormalities and positively correlated with motor performance as evaluated by the Childhood Myositis Assessment Scale and by manual muscle strength testing. CONCLUSION: Muscle ISG15 expression is strongly associated with juvenile DM, with patients exhibiting a different ISG-15 muscle signature according to their MSA class. Patients with juvenile DM who are positive for MDA-5 have higher expression of ISG15 in both gene form and protein form compared to the other subgroups. Moreover, our data show that negative regulation of type I IFN correlates with milder muscle involvement.
引用
- Hou C, Durrleman C, Periou B, et al. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies. Arthritis Rheumatol. 2021. PMID: 33314705. doi:10.1002/art.41625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。